Source: Biochemical Pharmacology. Unidade: FMRP
Subjects: FARMACOLOGIA, AORTA, PRESSÃO SANGUÍNEA, HIPERTENSÃO, METALOPROTEINASES, ANTAGONISTAS
ABNT
MATTOS, B. R. et al. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure. Biochemical Pharmacology, v. 180, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2020.114121. Acesso em: 30 set. 2024.APA
Mattos, B. R., Bonacio, G. F., Vitorino, T. R., Garcia, V. T., Amaral, J. H., Dellalibera-Joviliano, R., et al. (2020). TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure. Biochemical Pharmacology, 180. doi:10.1016/j.bcp.2020.114121NLM
Mattos BR, Bonacio GF, Vitorino TR, Garcia VT, Amaral JH, Dellalibera-Joviliano R, França SC, Tanus-Santos JE, Rizzi E. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure [Internet]. Biochemical Pharmacology. 2020 ; 180[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.bcp.2020.114121Vancouver
Mattos BR, Bonacio GF, Vitorino TR, Garcia VT, Amaral JH, Dellalibera-Joviliano R, França SC, Tanus-Santos JE, Rizzi E. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure [Internet]. Biochemical Pharmacology. 2020 ; 180[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.bcp.2020.114121